4
Changes in Ownership
Niagen Bioscience, Inc. Filed Acc 0001415889-11-001374
CEO bought 7,500 shares at $0.60 ($4,500)
From the SEC's structured data for this filing
Trades in this filing
Jaksch Frank L Jr · CEO
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2011-12-07 | Purchase : show line 1 in the form | +7,500 | $0.60 | $4,500 | 12,500 | D |
| Open-market purchases · 7,500 sh · avg $0.60 · $4,500 | ||||||
Loading xslF345X03/form4-12082011_101235.xml…